SE9001111D0 - Supportive use - Google Patents

Supportive use

Info

Publication number
SE9001111D0
SE9001111D0 SE9001111A SE9001111A SE9001111D0 SE 9001111 D0 SE9001111 D0 SE 9001111D0 SE 9001111 A SE9001111 A SE 9001111A SE 9001111 A SE9001111 A SE 9001111A SE 9001111 D0 SE9001111 D0 SE 9001111D0
Authority
SE
Sweden
Prior art keywords
methyl
treatment
supportive use
supportive
linomide
Prior art date
Application number
SE9001111A
Other languages
English (en)
Swedish (sv)
Inventor
T Kalland
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9001111A priority Critical patent/SE9001111D0/xx
Publication of SE9001111D0 publication Critical patent/SE9001111D0/xx
Priority to ES91907089T priority patent/ES2089206T3/es
Priority to CA002077996A priority patent/CA2077996C/en
Priority to AT91907089T priority patent/ATE139695T1/de
Priority to EP91907089A priority patent/EP0522001B1/en
Priority to DK91907089.6T priority patent/DK0522001T3/da
Priority to PCT/SE1991/000204 priority patent/WO1991014432A1/en
Priority to AU75623/91A priority patent/AU640223B2/en
Priority to DE69120529T priority patent/DE69120529T2/de
Priority to JP3506524A priority patent/JPH05505194A/ja
Priority to IE97391A priority patent/IE76287B1/en
Priority to PT97184A priority patent/PT97184B/pt
Priority to US08/222,002 priority patent/US5504092A/en
Priority to GR960402025T priority patent/GR3020667T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
SE9001111A 1990-03-27 1990-03-27 Supportive use SE9001111D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9001111A SE9001111D0 (sv) 1990-03-27 1990-03-27 Supportive use
JP3506524A JPH05505194A (ja) 1990-03-27 1991-03-20 リンパ系細胞の再生促進剤
PCT/SE1991/000204 WO1991014432A1 (en) 1990-03-27 1991-03-20 Supportive use
CA002077996A CA2077996C (en) 1990-03-27 1991-03-20 Roquinimex for supportive use
AT91907089T ATE139695T1 (de) 1990-03-27 1991-03-20 Unterstützende verwendung von linomide (r)
EP91907089A EP0522001B1 (en) 1990-03-27 1991-03-20 Supportive use of linomide (r)
DK91907089.6T DK0522001T3 (da) 1990-03-27 1991-03-20 Understøttende anvendelse af Linomide
ES91907089T ES2089206T3 (es) 1990-03-27 1991-03-20 Uso para mantenimiento de linomide(r).
AU75623/91A AU640223B2 (en) 1990-03-27 1991-03-20 Supportive use
DE69120529T DE69120529T2 (de) 1990-03-27 1991-03-20 Unterstützende verwendung von linomide (r)
IE97391A IE76287B1 (en) 1990-03-27 1991-03-22 Supportive use of Linomide (R)
PT97184A PT97184B (pt) 1990-03-27 1991-03-27 Processo para a preparacao de composicoes farmaceutica uteis no tratamento de seres humanos submetidos a transplante de medula ossea, tratamento citostatico ou irradiacao
US08/222,002 US5504092A (en) 1990-03-27 1994-04-04 Use of Linomide to increase hemopoietic cell precursors
GR960402025T GR3020667T3 (en) 1990-03-27 1996-07-31 Supportive use of linomide (r)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001111A SE9001111D0 (sv) 1990-03-27 1990-03-27 Supportive use

Publications (1)

Publication Number Publication Date
SE9001111D0 true SE9001111D0 (sv) 1990-03-27

Family

ID=20379010

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001111A SE9001111D0 (sv) 1990-03-27 1990-03-27 Supportive use

Country Status (13)

Country Link
EP (1) EP0522001B1 (xx)
JP (1) JPH05505194A (xx)
AT (1) ATE139695T1 (xx)
AU (1) AU640223B2 (xx)
CA (1) CA2077996C (xx)
DE (1) DE69120529T2 (xx)
DK (1) DK0522001T3 (xx)
ES (1) ES2089206T3 (xx)
GR (1) GR3020667T3 (xx)
IE (1) IE76287B1 (xx)
PT (1) PT97184B (xx)
SE (1) SE9001111D0 (xx)
WO (1) WO1991014432A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
EP0522001B1 (en) 1996-06-26
PT97184B (pt) 1998-07-31
WO1991014432A1 (en) 1991-10-03
JPH05505194A (ja) 1993-08-05
ATE139695T1 (de) 1996-07-15
GR3020667T3 (en) 1996-10-31
DK0522001T3 (da) 1996-09-16
ES2089206T3 (es) 1996-10-01
CA2077996C (en) 1996-03-12
IE76287B1 (en) 1997-10-08
PT97184A (pt) 1991-12-31
DE69120529T2 (de) 1997-01-30
AU7562391A (en) 1991-10-21
EP0522001A1 (en) 1993-01-13
CA2077996A1 (en) 1991-09-28
AU640223B2 (en) 1993-08-19
DE69120529D1 (de) 1996-08-01
IE910973A1 (en) 1991-10-09

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
MX9203772A (es) Derivados de quinolina como antagonistas del leucotrieno d4.
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
ES529315A0 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
IL57853A0 (en) Pseudotrisaccharides,their production and their use as medicaments
SE9001111D0 (sv) Supportive use
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
ES528792A0 (es) Procedimiento para la produccion de 3,4-di-(metilamino)-6-tercibutil-4,5-dihidro-1,2,4-triacin-5-ona
ES2073271T3 (es) Procedimiento para la fabricacion de benzolsulfonamidas.
SE9000300A (xx)
DE69214647D1 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
FI942505A (fi) Antibakteriella aemnen
ES2016857B3 (es) Derivados de 4 - feniltiazol.
NO910703D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.
NO910704D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.
NO911010D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.
NO911011D0 (no) Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter.